ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA
Tracking # 20-1064284
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALK(-) ALCL) IS AN UNCOMMON CD30-POSITIVE T-CELL LYMPHOMA THAT PRESENTS A MAJOR DIAGNOSTIC CHALLENGE. IT AFFECTS INDIVIDUALS IN A WIDE AGE RANGE AND A VARIETY OF NODAL AND EXTRANODAL SITES. BOTH MORPHOLOGICALLY AND IMMUNOHISTOCHEMICALLY, ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) CAN MIMIC MANY OTHER HEMATOLOGIC AND NON-HEMATOLOGIC MALIGNANCIES. THIS ACTIVITY EXPLAINS HOW TO PROPERLY EVALUATE FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN CARING FOR PATIENTS WITH THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.5h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.5h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.5h
AMA Category I
Physician Assistant
1.5h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.5h
AMA Category I